Cetrotide

Cetrotide is a brand name of cetrorelix, approved by the FDA in the following formulation(s):

CETROTIDE (cetrorelix - injectable; injection)

• 
  Manufacturer: EMD SERONO
  
  Approval date: August 11, 2000
  
  Strength(s): EQ 0.25MG BASE/ML ^[RLD], EQ 3MG BASE/ML ^[RLD]

Has a generic version of Cetrotide been approved?

No. There is currently no therapeutically equivalent version of Cetrotide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cetrotide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for the treatment of fertility disorders
  Patent 6,319,192
  Issued: November 20, 2001
  Inventor(s): Engel; Jurgen & Riethmuller-Winzen; Hilde & Reissmann; Thomas
  Assignee(s): Zentaris AG
  An improvement to the method of intrauterine insemination by the administration of luteinizing hormone-releasing hormone antagonists (LHRH antagonists).
  
  Patent expiration dates:
  
  
  • April 23, 2019
    
    ✓ 
    Patent use: PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION
  
  



• 
  Oligopeptide lyophilisate, their preparation and use
  Patent 6,863,891
  Issued: March 8, 2005
  Inventor(s): Engel; Jürgen & Wichert; Burkhard & Sauerbier; Dieter & Reissmann; Thomas
  Assignee(s): Zentaris AG
  A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried.
  
  Patent expiration dates:
  
  
  • February 22, 2014
    
    ✓ 
    Patent use: PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION
  
  



• 
  Oligopeptide lyophilisate, their preparation and use
  Patent 7,605,121
  Issued: October 20, 2009
  Inventor(s): Engel; Jürgen & Wichert; Burkhard & Sauerbier; Dieter & Reissmann; Thomas
  Assignee(s): AEterna Zentaris GmbH
  A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried.
  
  Patent expiration dates:
  
  
  • February 22, 2014
    
    ✓ 
    Drug product
  
  

See also...

• Cetrotide Consumer Information (Wolters Kluwer)
• Cetrotide injectable Consumer Information (Cerner Multum)
• Cetrotide Advanced Consumer Information (Micromedex)
• Cetrotide AHFS DI Monographs (ASHP)
• Cetrorelix Acetate Consumer Information (Wolters Kluwer)
• Cetrorelix injectable Consumer Information (Cerner Multum)
• Cetrorelix Subcutaneous Advanced Consumer Information (Micromedex)
• Cetrorelix Acetate AHFS DI Monographs (ASHP)